Oak JH - Search Results

1

Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells.

Oak JH, Nakagawa K, Oikawa S, Miyazawa T. Oak JH, et al. FEBS Lett. 2003 Dec 4;555(2):419-23. doi: 10.1016/s0014-5793(03)01237-7. FEBS Lett. 2003. PMID: 14644453 Free article.

2

UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples.

Oak JH, Nakagawa K, Miyazawa T. Oak JH, et al. J Lipid Res. 2002 Mar;43(3):523-9. J Lipid Res. 2002. PMID: 11893788 Free article.

3

A convenient method for preparation of high-purity, Amadori-glycated phosphatidylethanolamine and its prooxidant effect.

Miyazawa T, Oak JH, Nakagawa K. Miyazawa T, et al. Among authors: oak jh. Ann N Y Acad Sci. 2005 Jun;1043:276-9. doi: 10.1196/annals.1333.033. Ann N Y Acad Sci. 2005. PMID: 16037248

4

Tandem mass spectrometry analysis of Amadori-glycated phosphatidylethanolamine in human plasma.

Miyazawa T, Oak JH, Nakagawa K. Miyazawa T, et al. Among authors: oak jh. Ann N Y Acad Sci. 2005 Jun;1043:280-3. doi: 10.1196/annals.1333.034. Ann N Y Acad Sci. 2005. PMID: 16037249

5

Angiogenic potency of Amadori-glycated phosphatidylethanolamine.

Nakagawa K, Oak JH, Miyazawa T. Nakagawa K, et al. Among authors: oak jh. Ann N Y Acad Sci. 2005 Jun;1043:413-6. doi: 10.1196/annals.1333.048. Ann N Y Acad Sci. 2005. PMID: 16037263

6

Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes.

Nakagawa K, Oak JH, Higuchi O, Tsuzuki T, Oikawa S, Otani H, Mune M, Cai H, Miyazawa T. Nakagawa K, et al. Among authors: oak jh. J Lipid Res. 2005 Nov;46(11):2514-24. doi: 10.1194/jlr.D500025-JLR200. Epub 2005 Sep 8. J Lipid Res. 2005. PMID: 16150834 Free article.

7

Synthetically prepared Aamadori-glycated phosphatidylethanolaminecan trigger lipid peroxidation via free radical reactions.

Oak J, Nakagawa K, Miyazawa T. Oak J, et al. FEBS Lett. 2000 Sep 8;481(1):26-30. doi: 10.1016/s0014-5793(00)01966-9. FEBS Lett. 2000. PMID: 10984609 Free article.

8

The occurrence of a novel hydrophilic hydroperoxide, 3-hydroxy-5-hydroperoxy-2-methyl-5,6-dihydropyran-4-one, as a reactive glycation product in human plasma.

Lertsiri S, Oak JH, Nakagawa K, Miyazawa T. Lertsiri S, et al. Among authors: oak jh. Biochim Biophys Acta. 2002 Oct 10;1573(1):48-54. doi: 10.1016/s0304-4165(02)00330-6. Biochim Biophys Acta. 2002. PMID: 12383941

9

Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.

Oak JH, Cai H. Oak JH, et al. Diabetes. 2007 Jan;56(1):118-26. doi: 10.2337/db06-0288. Diabetes. 2007. PMID: 17192473

10

Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabetic mice.

Oak JH, Youn JY, Cai H. Oak JH, et al. Cardiovasc Diabetol. 2009 Dec 30;8:65. doi: 10.1186/1475-2840-8-65. Cardiovasc Diabetol. 2009. PMID: 20040119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters